China's Biotech Is Quietly Eating Big Pharma's Lunch
Warning! GuruFocus has detected 7 Warning Signs with AKESF.
Multinational pharma isn't waiting around. Pfizer (NYSE:PFE) just cut a $1.2 billion upfront deal with 3SBio. Summit Therapeutics paid $500 million for rights to Akeso's cancer therapy. These aren't niche plays they're big bets on the future. And with China's massive patient pool and streamlined hospital network, companies can run trials in half the time (and at a fraction of the cost) compared to the US. That speed lets Chinese firms launch multiple shots on goal and global players are lining up to license the winners. From cell therapies to obesity drugs, the East is becoming the place where the drug pipeline gets built.
But approval is still a long game. US regulators aren't greenlighting drugs based solely on China trial data not yet. And with rising geopolitical tension, some in Washington are sounding alarms over biotech dependencies. Still, the shift is underway. In just five years, the number of top-ranked Chinese drug innovators has quadrupled. Investors watching this space aren't asking whether China will lead the next wave of biotech innovation. They're asking how soon.
This article first appeared on GuruFocus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
PNC Financial Services Group (PNC) Q2 Earnings: What To Expect
Financial services giant PNC (NYSE:PNC) will be announcing earnings results this Wednesday before market hours. Here's what to expect. PNC Financial Services Group met analysts' revenue expectations last quarter, reporting revenues of $5.45 billion, up 6% year on year. It was a mixed quarter for the company, with a solid beat of analysts' tangible book value per share estimates but EPS in line with analysts' estimates. Is PNC Financial Services Group a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting PNC Financial Services Group's revenue to grow 3.3% year on year to $5.59 billion, improving from the 2.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $3.56 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 10 downward revisions over the last 30 days (we track 11 analysts). PNC Financial Services Group has missed Wall Street's revenue estimates five times over the last two years. Looking at PNC Financial Services Group's peers in the banks segment, only FB Financial has reported results so far. It missed analysts' revenue estimates by 43.5%, posting year-on-year sales declines of 40.1%. Read our full analysis of FB Financial's earnings results here. There has been positive sentiment among investors in the banks segment, with share prices up 11.6% on average over the last month. PNC Financial Services Group is up 12.7% during the same time and is heading into earnings with an average analyst price target of $209.33 (compared to the current share price of $197.40). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
Earnings To Watch: Bank of America (BAC) Reports Q2 Results Tomorrow
Financial services giant Bank of America (NYSE:BAC) will be announcing earnings results this Wednesday before market open. Here's what you need to know. Bank of America beat analysts' revenue expectations by 2.1% last quarter, reporting revenues of $27.37 billion, up 6% year on year. It was a satisfactory quarter for the company, with a decent beat of analysts' EPS estimates but a slight miss of analysts' net interest income estimates. Is Bank of America a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Bank of America's revenue to grow 4.5% year on year to $26.52 billion, improving from its flat revenue in the same quarter last year. Adjusted earnings are expected to come in at $0.86 per share. Heading into earnings, analysts covering the company have mixed opinions about the business, with revenue estimates seeing 6 upward and 5 downward revisions over the last 30 days. Bank of America has missed Wall Street's revenue estimates twice over the last two years. Looking at Bank of America's peers in the banks segment, only FB Financial has reported results so far. It missed analysts' revenue estimates by 43.5%, posting year-on-year sales declines of 40.1%. Read our full analysis of FB Financial's earnings results here. There has been positive sentiment among investors in the banks segment, with share prices up 11.6% on average over the last month. Bank of America is up 6.1% during the same time and is heading into earnings with an average analyst price target of $52.35 (compared to the current share price of $47.10). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
23 minutes ago
- Yahoo
Synovus Financial (SNV) Reports Earnings Tomorrow: What To Expect
Regional banking company Synovus Financial (NYSE:SNV) will be reporting results this Wednesday after the bell. Here's what you need to know. Synovus Financial met analysts' revenue expectations last quarter, reporting revenues of $570.9 million, up 6.2% year on year. It was a very strong quarter for the company, with an impressive beat of analysts' EPS estimates and a solid beat of analysts' net interest income estimates. Is Synovus Financial a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Synovus Financial's revenue to grow 91.1% year on year to $585.1 million, a reversal from the 46.1% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.26 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Synovus Financial has missed Wall Street's revenue estimates four times over the last two years. Looking at Synovus Financial's peers in the banks segment, only FB Financial has reported results so far. It missed analysts' revenue estimates by 43.5%, posting year-on-year sales declines of 40.1%. Read our full analysis of FB Financial's earnings results here. There has been positive sentiment among investors in the banks segment, with share prices up 11.6% on average over the last month. Synovus Financial is up 14.3% during the same time and is heading into earnings with an average analyst price target of $59.44 (compared to the current share price of $54.69). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
